RENOVARO INC. - COMMON STOCK

Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection

12 Jul 2021 07:00:01 By Nasdaq GlobeNewswire

Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity

30 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology

21 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

14 Jun 2021 14:53:19 By Nasdaq GlobeNewswire

Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure

14 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy

12 May 2021 16:29:11 By Nasdaq GlobeNewswire

Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy

12 May 2021 08:00:01 By Nasdaq GlobeNewswire

Seraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Remission of Recurrent Glioblastoma with Innovative Therapy

24 Mar 2021 18:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences to Present to Investors at the H.C. Wainwright Global Life Sciences Conference

22 Feb 2021 17:15:00 By Nasdaq GlobeNewswire